These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3496128)

  • 1. [Sensitization to the influenza virus in a combined experimental infection].
    Gönczi S
    Biull Eksp Biol Med; 1987 May; 103(5):603-6. PubMed ID: 3496128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitizing properties of soluble Haemophilus influenzae antigens].
    Dobritsa VP; Sukhodoeva GS; Beklemishev ND
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):59-62. PubMed ID: 3489339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to influenza virus in rabbits after local immunization. II. Local and systemic cell mediated response.
    Kasturi K; Hannoun C
    Ann Microbiol (Paris); 1977 Apr; 128A(3):349-64. PubMed ID: 921142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effect of oral immunization against influenza with a live vaccine in mice].
    Noack K; Bergmann KC; Pohl WD; Tischner H; Luther P
    Z Erkr Atmungsorgane; 1985; 164(1):79-82. PubMed ID: 3984402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice.
    Semkow R; Loza-Tulimowska M; Wilczyński J; Brydak L; Zgorzelska K
    Acta Microbiol Pol; 1982; 31(2):185-94. PubMed ID: 6188341
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.
    Crawford CR; Jennings R; Bradford N; Potter CW
    Clin Exp Immunol; 1982 Jun; 48(3):739-46. PubMed ID: 6811173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
    Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
    J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model.
    Liu B; Hossain MJ; Mori I; Kimura Y
    J Med Virol; 2008 May; 80(5):888-94. PubMed ID: 18360902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to influenza in ferrets. IX. Delayed hypersensitivity following infection or immunization with A2/Hong Kong virus.
    Potter CW; Rees RC; Shore SL; Jennings R; McLaren C
    Microbios; 1974; 10A SUPPL(41):7-21. PubMed ID: 4218297
    [No Abstract]   [Full Text] [Related]  

  • 16. The infant rat as a model for assessment of the attenuation of human influenza viruses.
    Mahmud MI; Jennings R; Potter CW
    J Med Microbiol; 1979 Feb; 12(1):43-54. PubMed ID: 311833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Seo SU; Lee KH; Byun YH; Kweon MN; Seong BL
    Vaccine; 2007 Nov; 25(47):8067-76. PubMed ID: 17919786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.